Alpine Global Management’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-57,528	Closed	-$266K	–	210
2024 Q2	$266K	Buy	+57,528	New	+$266K	0.05%	256
2023 Q1	–	Sell	-18,574	Closed	-$110K	–	192
2022 Q4	$110K	Buy	+18,574	New	+$110K	0.04%	235